Qsymia sanctioned for obese or overweight people with chronic condition WEDNESDAY, July 18 (HealthDay News) — Qsymia (phentermine and topiramate extended-release) has been approved by the U.S. Food and Drug Administration, making it the second weight-loss drug to be given the agency’s green light in less than a month. In June, the agency sanctioned Belviq,...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Lack of exercise linked to cancer, diabetes and heart disease, which cause about 10% of deaths worldwide WEDNESDAY, July 18 (HealthDay News) — Inactivity is a major cause of death worldwide, with new research suggesting that a sedentary lifestyle is on par with both smoking and obesity when it comes to raising the risk for...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Children consume more sweetened beverages each day, but also keep drinking milk, 100% fruit juice WEDNESDAY, July 18 (HealthDay News) — U.S. children drink less milk and more sugar-sweetened beverages, such as sodas and flavored fruit drinks, as they get older, but such unhealthy drinks don’t actually replace milk in kids’ diets, researchers have found....

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Qsymia joins Belviq as first diet medications approved in 13 years; experts still counsel healthy lifestyle as best option By Steven ReinbergHealthDay Reporter TUESDAY, July 17 (HealthDay News) — For the second time in less than a month, U.S. drug regulators on Tuesday approved a new weight-loss medication. Qsymia — formerly dubbed Qnexa — is...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]